Market Cap 1.20B
Revenue (ttm) 1.01B
Net Income (ttm) -204.71M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -20.17%
Debt to Equity Ratio 0.00
Volume 2,284,100
Avg Vol 1,913,918
Day's Range N/A - N/A
Shares Out 69.58M
Stochastic %K 17%
Beta 1.55
Analysts Strong Sell
Price Target $29.36

Company Profile

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device...

Industry: Medical Devices
Sector: Healthcare
Phone: 858 366 6900
Address:
12400 High Bluff Drive, San Diego, United States
deepthinker
deepthinker Sep. 18 at 1:44 PM
$BBNX This company is going to crush hapless $TNDM, and start taking patch pump market share from $PODD in 2027.
0 · Reply
BriOnH
BriOnH Sep. 16 at 4:47 PM
$SANA $ELDN $DXCM $PODD $TNDM "Australia-based Endo Axiom Pty Ltd has dosed its first human participants with an oral nanoparticle-encapsulated insulin formulation, marking the company's transition to clinical stage after extensive preclinical development. " https://www.chemdiv.com/company/media/pharma-news/2026/endo-axiom-takes-oral-nanoparticle-insulin-into-first-in-human-trial-run/
1 · Reply
kp8claw
kp8claw Sep. 16 at 4:31 PM
$TNDM | $17.88 | Vol: 956K | RE·RVOL=0.62·F=64M | MUP_1 | Long
0 · Reply
deepthinker
deepthinker Sep. 16 at 2:42 PM
$MODD Beta is raising $150 million. That’s really smart. With their patch pump coming, they can really stick the knife in $TNDM, which has only a fake patch pump coming, and begin to chip away at $PODD. These guys do everything right.
0 · Reply
deepthinker
deepthinker Sep. 16 at 2:08 PM
$TNDM Will patients be convinced that Mobi tubeless is really a patch pump (when it’s actually not).
0 · Reply
deepthinker
deepthinker Sep. 13 at 7:08 PM
$TNDM The day Sheridan was named CEO in 2019, the stock was $69. It’s a miracle that a 70 year-old turns in a 75% decline over 7+ years and is still there.
0 · Reply
BriOnH
BriOnH Sep. 11 at 6:32 PM
$SANA $ELDN $DXCM $PODD $TNDM It appears it is safe to assume Endo Axiom's Smart Oral insulin is now in human(s). Please Jesus let this work. This will ineffably transform the lives for us T1D's. Sana with sc451 is still on the horizon with Ph 1/2 to begin this year, IMHO the best potential option. Tego + Cadaveric islets is here RIGHT NOW with 12 out of 12 people (functionally) cured. T1D your days are numbered bitch. https://www.sydney.edu.au/news-opinion/news/2026/09/10/oral-insulin-drug-achieves-a-critical-milestone--.html
1 · Reply
MODDBlueInMyBlood
MODDBlueInMyBlood Sep. 10 at 5:04 PM
$MODD $MODD $TNDM $PODD $MDT @Stef_Gee Lets debate MODD stock LETS TALK ANALYTICS LETS SETTLE THIS
1 · Reply
MODDBlueInMyBlood
MODDBlueInMyBlood Sep. 10 at 4:45 PM
$MODD my days on this app may be numbered. My recent post about @Stef_Gee was taken down I AM HERE FOR REAL STOCK ANALYSIS. But most people are too afraid to face the truth. Ready to debate $MODD with anyone $TNDM $PODD $MDT If anyone doubts modd is the next big thing i am ready to defend it. Respond.
1 · Reply
JInvestTrade
JInvestTrade Sep. 10 at 11:46 AM
$SENS $DXCM $TNDM $PODD $ABT https://lnkd.in/p/eTiFrp-W
0 · Reply
Latest News on TNDM
Tandem Diabetes initiated with an Outperform at William Blair

2026-08-21T12:20:38.000Z - 4 weeks ago

Tandem Diabetes initiated with an Outperform at William Blair


Tandem Diabetes price target raised to $24 from $21 at Citi

2026-08-17T08:21:18.000Z - 4 weeks ago

Tandem Diabetes price target raised to $24 from $21 at Citi


Tandem Diabetes price target raised to $21 from $17 at Citi

2026-08-07T11:05:52.000Z - 6 weeks ago

Tandem Diabetes price target raised to $21 from $17 at Citi


Tandem Diabetes Care Earnings Call Transcript: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 6 weeks ago

Tandem Diabetes Care Earnings Call Transcript: Q2 2026


Tandem Diabetes Care Slides: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 6 weeks ago

Tandem Diabetes Care Slides: Q2 2026


Tandem Diabetes Care Earnings release: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 6 weeks ago

Tandem Diabetes Care Earnings release: Q2 2026


Tandem Diabetes Care Quarterly report: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 6 weeks ago

Tandem Diabetes Care Quarterly report: Q2 2026


Tandem Diabetes Care Announces Upcoming Conference Presentation

Jul 28, 2026, 4:05 PM EDT - 7 weeks ago

Tandem Diabetes Care Announces Upcoming Conference Presentation


Tandem Diabetes resumed with a Neutral at UBS

2026-07-28T12:01:16.000Z - 7 weeks ago

Tandem Diabetes resumed with a Neutral at UBS


Tandem Diabetes price target lowered to $20 from $24 at Mizuho

2026-07-15T11:31:50.000Z - 2 months ago

Tandem Diabetes price target lowered to $20 from $24 at Mizuho


Tandem Diabetes initiated with a Hold at Deutsche Bank

2026-06-23T16:55:55.000Z - 2 months ago

Tandem Diabetes initiated with a Hold at Deutsche Bank


Tandem Diabetes price target lowered to $17 from $22 at Citi

2026-05-28T12:13:20.000Z - 3 months ago

Tandem Diabetes price target lowered to $17 from $22 at Citi


Tandem Diabetes Care Transcript: AGM 2026

May 20, 2026, 6:00 PM EDT - 4 months ago

Tandem Diabetes Care Transcript: AGM 2026


Tandem Diabetes Care Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 4 months ago

Tandem Diabetes Care Earnings Call Transcript: Q1 2026


Tandem Diabetes Care Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 4 months ago

Tandem Diabetes Care Earnings release: Q1 2026


Tandem Diabetes Care Quarterly report: Q1 2026

May 7, 2026, 4:30 PM EDT - 4 months ago

Tandem Diabetes Care Quarterly report: Q1 2026


Tandem Diabetes Care Slides: Q1 2026

May 7, 2026, 4:30 PM EDT - 4 months ago

Tandem Diabetes Care Slides: Q1 2026


Tandem Diabetes Care Announces Upcoming Conference Presentations

Apr 29, 2026, 4:05 PM EDT - 4 months ago

Tandem Diabetes Care Announces Upcoming Conference Presentations


Tandem Diabetes Care Proxy statement: Proxy filing

Apr 7, 2026, 8:00 AM EDT - 5 months ago

Tandem Diabetes Care Proxy statement: Proxy filing


Tandem Diabetes Care Proxy statement: Proxy filing

Apr 7, 2026, 8:00 AM EDT - 5 months ago

Tandem Diabetes Care Proxy statement: Proxy filing


Tandem Diabetes Care, Inc. Investigated by the Portnoy Law Firm

Mar 27, 2026, 9:00 AM EDT - 5 months ago

Tandem Diabetes Care, Inc. Investigated by the Portnoy Law Firm


Tandem Diabetes Care Proxy statement: Proxy filing

Mar 27, 2026, 8:00 AM EDT - 5 months ago

Tandem Diabetes Care Proxy statement: Proxy filing


Tandem Mobi Now Compatible with Android Smartphones

Mar 4, 2026, 5:00 PM EST - 6 months ago

Tandem Mobi Now Compatible with Android Smartphones


Tandem Diabetes Care Earnings Call Transcript: Q4 2025

Feb 19, 2026, 4:30 PM EST - 7 months ago

Tandem Diabetes Care Earnings Call Transcript: Q4 2025


Tandem Diabetes Care Annual report: Q4 2025

Feb 19, 2026, 4:30 PM EST - 7 months ago

Tandem Diabetes Care Annual report: Q4 2025


Tandem Diabetes Care Earnings release: Q4 2025

Feb 19, 2026, 4:30 PM EST - 7 months ago

Tandem Diabetes Care Earnings release: Q4 2025


Tandem Diabetes Care Slides: Q4 2025

Feb 19, 2026, 4:30 PM EST - 7 months ago

Tandem Diabetes Care Slides: Q4 2025


Tandem Diabetes Care Annual report: Q4 2025

Feb 19, 2026, 4:30 PM EST - 7 months ago

Tandem Diabetes Care Annual report: Q4 2025


Tandem t:slim Mobile App Now Available in Canada

Dec 18, 2025, 9:00 AM EST - 9 months ago

Tandem t:slim Mobile App Now Available in Canada


Tandem Diabetes Care Transcript: Stifel 2025 Healthcare Conference

Nov 11, 2025, 10:40 AM EST - 10 months ago

Tandem Diabetes Care Transcript: Stifel 2025 Healthcare Conference


Tandem Diabetes Care Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Tandem Diabetes Care Earnings Call Transcript: Q3 2025


Tandem Diabetes Care Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Tandem Diabetes Care Quarterly report: Q3 2025


Tandem Diabetes Care Earnings release: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Tandem Diabetes Care Earnings release: Q3 2025


Tandem Diabetes Care Slides: Corporate Presentation

Nov 5, 2025, 6:00 PM EST - 10 months ago

Tandem Diabetes Care Slides: Corporate Presentation


Tandem Diabetes Care Earnings Call Transcript: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Tandem Diabetes Care Earnings Call Transcript: Q2 2025


Tandem Diabetes Care Quarterly report: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Tandem Diabetes Care Quarterly report: Q2 2025


Tandem Diabetes Care Earnings release: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Tandem Diabetes Care Earnings release: Q2 2025


Tandem Diabetes Care Slides: Corporate presentation

Aug 6, 2025, 4:00 PM EDT - 1 year ago

Tandem Diabetes Care Slides: Corporate presentation


Tandem Diabetes Care Earnings Call Transcript: Q1 2025

Apr 30, 2025, 4:30 PM EDT - 1 year ago

Tandem Diabetes Care Earnings Call Transcript: Q1 2025


Tandem Diabetes Care Quarterly report: Q1 2025

Apr 30, 2025, 4:30 PM EDT - 1 year ago

Tandem Diabetes Care Quarterly report: Q1 2025


Tandem Diabetes Care Earnings release: Q1 2025

Apr 30, 2025, 4:30 PM EDT - 1 year ago

Tandem Diabetes Care Earnings release: Q1 2025


Tandem Diabetes Care Slides: Corporate presentation

Apr 30, 2025, 9:30 AM EDT - 1 year ago

Tandem Diabetes Care Slides: Corporate presentation


Tandem Diabetes Care Proxy statement: Proxy Filing

Apr 8, 2025, 8:00 AM EDT - 1 year ago

Tandem Diabetes Care Proxy statement: Proxy Filing


Tandem Diabetes Care Proxy statement: Proxy Filing

Apr 8, 2025, 8:00 AM EDT - 1 year ago

Tandem Diabetes Care Proxy statement: Proxy Filing


Tandem Diabetes Care Earnings Call Transcript: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

Tandem Diabetes Care Earnings Call Transcript: Q4 2024


Tandem Diabetes Care Annual report: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

Tandem Diabetes Care Annual report: Q4 2024


Tandem Diabetes Care Earnings release: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

Tandem Diabetes Care Earnings release: Q4 2024


Tandem Diabetes Care Slides: Corporate presentation

Feb 26, 2025, 4:00 PM EST - 1 year ago

Tandem Diabetes Care Slides: Corporate presentation


Tandem Diabetes Care Earnings Call Transcript: Q3 2024

Nov 6, 2024, 4:30 PM EST - 1 year ago

Tandem Diabetes Care Earnings Call Transcript: Q3 2024


Tandem Diabetes Care Quarterly report: Q3 2024

Nov 6, 2024, 4:30 PM EST - 1 year ago

Tandem Diabetes Care Quarterly report: Q3 2024


Tandem Diabetes Care Earnings release: Q3 2024

Nov 6, 2024, 4:30 PM EST - 1 year ago

Tandem Diabetes Care Earnings release: Q3 2024


Tandem Diabetes Care Slides: Corporate presentation

Nov 6, 2024, 4:00 PM EST - 1 year ago

Tandem Diabetes Care Slides: Corporate presentation


Tandem Diabetes Care Earnings Call Transcript: Q2 2024

Aug 1, 2024, 4:30 PM EDT - 2 years ago

Tandem Diabetes Care Earnings Call Transcript: Q2 2024


Tandem Diabetes Care Quarterly report: Q2 2024

Aug 1, 2024, 4:30 PM EDT - 2 years ago

Tandem Diabetes Care Quarterly report: Q2 2024


Tandem Diabetes Care Earnings release: Q2 2024

Aug 1, 2024, 4:30 PM EDT - 2 years ago

Tandem Diabetes Care Earnings release: Q2 2024


deepthinker
deepthinker Sep. 18 at 1:44 PM
$BBNX This company is going to crush hapless $TNDM, and start taking patch pump market share from $PODD in 2027.
0 · Reply
BriOnH
BriOnH Sep. 16 at 4:47 PM
$SANA $ELDN $DXCM $PODD $TNDM "Australia-based Endo Axiom Pty Ltd has dosed its first human participants with an oral nanoparticle-encapsulated insulin formulation, marking the company's transition to clinical stage after extensive preclinical development. " https://www.chemdiv.com/company/media/pharma-news/2026/endo-axiom-takes-oral-nanoparticle-insulin-into-first-in-human-trial-run/
1 · Reply
kp8claw
kp8claw Sep. 16 at 4:31 PM
$TNDM | $17.88 | Vol: 956K | RE·RVOL=0.62·F=64M | MUP_1 | Long
0 · Reply
deepthinker
deepthinker Sep. 16 at 2:42 PM
$MODD Beta is raising $150 million. That’s really smart. With their patch pump coming, they can really stick the knife in $TNDM, which has only a fake patch pump coming, and begin to chip away at $PODD. These guys do everything right.
0 · Reply
deepthinker
deepthinker Sep. 16 at 2:08 PM
$TNDM Will patients be convinced that Mobi tubeless is really a patch pump (when it’s actually not).
0 · Reply
deepthinker
deepthinker Sep. 13 at 7:08 PM
$TNDM The day Sheridan was named CEO in 2019, the stock was $69. It’s a miracle that a 70 year-old turns in a 75% decline over 7+ years and is still there.
0 · Reply
BriOnH
BriOnH Sep. 11 at 6:32 PM
$SANA $ELDN $DXCM $PODD $TNDM It appears it is safe to assume Endo Axiom's Smart Oral insulin is now in human(s). Please Jesus let this work. This will ineffably transform the lives for us T1D's. Sana with sc451 is still on the horizon with Ph 1/2 to begin this year, IMHO the best potential option. Tego + Cadaveric islets is here RIGHT NOW with 12 out of 12 people (functionally) cured. T1D your days are numbered bitch. https://www.sydney.edu.au/news-opinion/news/2026/09/10/oral-insulin-drug-achieves-a-critical-milestone--.html
1 · Reply
MODDBlueInMyBlood
MODDBlueInMyBlood Sep. 10 at 5:04 PM
$MODD $MODD $TNDM $PODD $MDT @Stef_Gee Lets debate MODD stock LETS TALK ANALYTICS LETS SETTLE THIS
1 · Reply
MODDBlueInMyBlood
MODDBlueInMyBlood Sep. 10 at 4:45 PM
$MODD my days on this app may be numbered. My recent post about @Stef_Gee was taken down I AM HERE FOR REAL STOCK ANALYSIS. But most people are too afraid to face the truth. Ready to debate $MODD with anyone $TNDM $PODD $MDT If anyone doubts modd is the next big thing i am ready to defend it. Respond.
1 · Reply
JInvestTrade
JInvestTrade Sep. 10 at 11:46 AM
$SENS $DXCM $TNDM $PODD $ABT https://lnkd.in/p/eTiFrp-W
0 · Reply
BriOnH
BriOnH Sep. 4 at 5:32 PM
$SANA $ELDN $DXCM $PODD $TNDM Today is scheduled to be the first person ever dosed with Endo Axium Smart Oral Insulin. This could potentially radically change the lives for us T1D's, with even better stuff on the horizon. 🙏🏻🤞
3 · Reply
RocketTrader11
RocketTrader11 Sep. 4 at 1:44 PM
$TNDM Modular Medical secures contract with national U.S. PBM to offer Pivot tubeless insulin patch pump
0 · Reply
jheerdink
jheerdink Sep. 4 at 1:30 PM
$MODD $ Modular Medical announced a contract with a national U.S. pharmacy benefit manager, expanding access to its Pivot™ tubeless patch-pump insulin delivery system as it prepares for its commercial launch. https://finance.yahoo.com/healthcare/articles/modular-medical-announces-contract-national-120000363.html #Diabetes #MedTech #InsulinPump $TNDM
0 · Reply
RocketTrader11
RocketTrader11 Sep. 3 at 1:19 PM
$TNDM Modular Medical wins FDA clearance for software enhancements to Pivot tubeless insulin patch pump Cleared software expands Pivot pump functionality and customization ahead of planned fourth-quarter 2026 commercial launch.
0 · Reply
StockConsultant
StockConsultant Sep. 1 at 1:20 PM
$TNDM Tandem Diabetes Care stock watch, strong day, attempting to rally off the 21.39 support area at https://www.stockconsultant.com/?TNDM Long Trade Target 1: 26.17 Profit: 18.9% Stop/Trailing Stop: 20.72 Loss: 5.9% P/L ratio: 3.2 : 1 - Good Target 2: 27.69 Profit: 25.8% P/L ratio: 4.4 : 1 - Excellent Extreme rally BULLISH [Positioning] Intermediate trend bullish, Uptrend. [Timing] Strong bullish 3 day candlestick pattern. [Timing] Good long trade quality BEARISH [Positioning] at resistance
0 · Reply
ortega1963
ortega1963 Aug. 31 at 6:22 PM
$TNDM wants to go up
0 · Reply
JamesTaulman
JamesTaulman Aug. 26 at 3:26 PM
TUE 8/25: $TNDM – SELLING (ALL) P/L: -$803.14 -8.0% 10:06 AM – Getting out of TNDM this morning as the technical picture continues to deteriorate. Shares have been (1) posting a series of lower highs, (2) making new recent lows, and (3) trading with the 10 DMA now clearly rolling over. At the same time, my loss has reached roughly 8%, which is about as far as I generally allow a position to move against me under my risk-management guidelines. I’m exiting here and protecting capital. ULTRA Trader’s Tip: Respect Your Maximum Loss • Lower highs and new lows show that the stock is moving in the wrong direction. • A rolling-over 10 DMA confirms that short-term momentum is deteriorating. • Once a loss reaches your predetermined threshold, discipline matters more than hope—take the loss and move on. https://buyingbreakouts.com/tue-8-25-tndm-selling-all-p-l-803-14-8-0/
0 · Reply
MODDBlueInMyBlood
MODDBlueInMyBlood Aug. 25 at 2:25 PM
$MODD attention weaklings $PODD small people $MDT and the rest $TNDM Take a read
0 · Reply
JeremyDanie
JeremyDanie Aug. 24 at 3:15 AM
$TNDM Shit stock
0 · Reply
JamesTaulman
JamesTaulman Aug. 21 at 4:47 PM
$TNDM - A break below $22 and I'm out.
1 · Reply
JamesTaulman
JamesTaulman Aug. 19 at 3:11 AM
TUE 8/18: $TNDM – BUYING (1/3) @ $23.49 3:31 PM – Picking up a 1/3 position in this Medical-Products company as shares advance from the 10 DMA on a 24% increase in daily volume. The stock also appears capable of closing above the previous high near $23.80, which would provide another bullish technical confirmation. There has not been much to choose from recently as both the market and individual stocks have remained relatively quiet during this mid-summer stretch following the peak of earnings season. TNDM stands out as one of the more promising opportunities currently showing the type of price-and-volume action that could produce some upside potential. James’ Trader’s Tip: Selectivity Matters in Quiet Markets • When fewer stocks are producing quality technical signals, there is no reason to force trades. • Focus on the names that continue to show clear support, improving volume, and bullish price action. • Quiet markets reward patience—and make the strongest individual opportunities stand out even more. https://buyingbreakouts.com/tue-8-18-tndm-buying-1-3-23-49/
0 · Reply
JFDI
JFDI Aug. 18 at 2:08 PM
0 · Reply